Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease
Book Details
AI Summary
Delivery Location
Delivery fee: Select location
Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process.
Get Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease by at the best price and quality guaranteed only at Werezi Africa's largest book ecommerce store. The book was published by National Academies Press and it has pages.
Discover books you might love based on this title.
More in This Genre
Policy Issues in the Clinical Development and Use of Immunotherapy for Cancer Treatment
Ksh 6,850.00
Clinical Neurophysiology
Ksh 12,600.00
Understanding DVT Laminated Poster
Ksh 4,300.00
Making Medicines Affordable
Ksh 8,800.00
Neisseria meningitidis
Ksh 22,950.00
Decolonising Social Work Education
Ksh 7,550.00